Open Access

Bioinformatics analysis of differentially expressed pathways related to the metastatic characteristics of osteosarcoma

  • Authors:
    • Wei Sun
    • Xiaojun Ma
    • Jiakang Shen
    • Fei Yin
    • Chongren Wang
    • Zhengdong Cai
  • View Affiliations

  • Published online on: June 27, 2016     https://doi.org/10.3892/ijmm.2016.2657
  • Pages: 466-474
  • Copyright: © Sun et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In this study, gene expression data of osteosarcoma (OSA) were analyzed to identify metastasis-related biological pathways. Four gene expression data sets (GSE21257, GSE9508, GSE49003 and GSE66673) were downloaded from Gene Expression Omnibus (GEO). An analysis of differentially expressed genes (DEGs) was performed using the Significance Analysis of Microarray (SAM) method. Gene expression levels were converted into scores of pathways by the Functional Analysis of Individual Microarray Expression (FAIME) algorithm and the differentially expressed pathways (DEPs) were then disclosed by a t-test. The distinguishing and prediction ability of the DEPs for metastatic and non-metastatic OSA was further confirmed using the principal component analysis (PCA) method and 3 gene expression data sets (GSE9508, GSE49003 and GSE66673) based on the support vector machines (SVM) model. A total of 616 downregulated and 681 upregulated genes were identified in the data set, GSE21257. The DEGs could not be used to distinguish metastatic OSA from non-metastatic OSA, as shown by PCA. Thus, an analysis of DEPs was further performed, resulting in 14 DEPs, such as NRAS signaling, Toll-like receptor (TLR) signaling, matrix metalloproteinase (MMP) regulation of cytokines and tumor necrosis factor receptor-associated factor (TRAF)-mediated interferon regulatory factor 7 (IRF7) activation. Cluster analysis indicated that these pathways could be used to distinguish between metastatic OSA from non-metastatic OSA. The prediction accuracy was 91, 66.7 and 87.5% for the data sets, GSE9508, GSE49003 and GSE66673, respectively. The results of PCA further validated that the DEPs could be used to distinguish metastatic OSA from non-metastatic OSA. On the whole, several DEPs were identified in metastatic OSA compared with non-metastatic OSA. Further studies on these pathways and relevant genes may help to enhance our understanding of the molecular mechanisms underlying metastasis and may thus aid in the development of novel therapies.

Related Articles

Journal Cover

August-2016
Volume 38 Issue 2

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Sun W, Ma X, Shen J, Yin F, Wang C and Cai Z: Bioinformatics analysis of differentially expressed pathways related to the metastatic characteristics of osteosarcoma. Int J Mol Med 38: 466-474, 2016
APA
Sun, W., Ma, X., Shen, J., Yin, F., Wang, C., & Cai, Z. (2016). Bioinformatics analysis of differentially expressed pathways related to the metastatic characteristics of osteosarcoma. International Journal of Molecular Medicine, 38, 466-474. https://doi.org/10.3892/ijmm.2016.2657
MLA
Sun, W., Ma, X., Shen, J., Yin, F., Wang, C., Cai, Z."Bioinformatics analysis of differentially expressed pathways related to the metastatic characteristics of osteosarcoma". International Journal of Molecular Medicine 38.2 (2016): 466-474.
Chicago
Sun, W., Ma, X., Shen, J., Yin, F., Wang, C., Cai, Z."Bioinformatics analysis of differentially expressed pathways related to the metastatic characteristics of osteosarcoma". International Journal of Molecular Medicine 38, no. 2 (2016): 466-474. https://doi.org/10.3892/ijmm.2016.2657